A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like ...
Q25 – – $32.0 million Revuforj® (revumenib) net revenue; total Revuforj prescriptions in 3Q25 increased 25% over 2Q25, highlighting strong demand – – $45.8 million Niktimvo™ (axatilimab-csfr) net ...
Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January ...
Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.
A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...
A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...
A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...
A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like ...
The Chosun Ilbo (English Edition) on MSN
Non-Smoker Lung Cancer Surge, Rycarza Effective for Brain Metastasis
According to the latest statistics from the Ministry of Data and Statistics, 21.9% of cancer-related deaths are attributed to ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback